Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-657-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
The following remarks on the toxicokinetics are based on the physico-chemical properties of the substance and on toxicological data. Experimental studies on toxicokinetics were not performed.
HDI oligomerisation product, allophanate-type is a colourless organic liquid (Currenta, 2011) with a pourpoint of -54 °C (atmospheric pressure; Bayer Industry Services, 2006), a very low vapour pressure of 0.0004 Pa (20 °C; Bayer Technology Services, 2011) and a dynamic viscosity of 249 mPa*s (20 °C; Bayer Industry Services, 2006). The substance is hydrolytically unstable with a half-life of approx. 24 hours at 20 °C (Currenta, 2013). In addition, water solubility of the substance is low (7.4 mg/L at a conc. of 1000 mg/mL; Currenta, 2012). Therefore experimental data such as pH or pKa could not be obtained. The log Pow was determined to be 5.9 (25 °C; Currenta, 2012), indicating a possible accumulation potential.
Due to the low vapour pressure and the high viscosity inhalation exposure via vapour is not to be expected. Wherever aerosolisation occurs exposure is possible. In acute inhalation toxicity studies the irritant port of entry toxicity was identified as the toxicological mode of action following exposure to the aerosol (Bayer, 2011 and 2013). No systemic toxicity was observed in these studies. Read across data on repeated dose toxicity reveal also no indications of systemic toxicity; all clinical signs were related to respiratory distress as a consequence of the irritant properties of the substance. These effects are most probably related to the chemical nature of the isocyanate-groups of the substance. Due to the physico-chemical properties of the oligomerisation product (high mean molecular weight, reaction with nucleophiles e.g. OH-, NH-, SH-groups) an extensive bioavailability via passive diffusion in the lung is not assumed, however, passive diffusion or active transport of the substance or its degradation products cannot be fully excluded.
Dermal absorption of HDI oligomerisation product, allophanate-type is assumed to be very low, due to its physico-chemical properties (high mean molecular weight, low water solubility / reaction with water, reaction with nucleophiles e.g. OH-, NH-, SH-groups). However, HDI oligomerisation product, allophanate-type has shown skin sensitizing properties (OECD TG 429, Bayer, 2011), thus indicating that a dermal uptake, even though small, can occur.
Based on the physico-chemical properties (high mean molecular weight, low water solubility / reaction with water, reaction with nucleophiles e.g. OH-, NH-, SH-groups) a significant absorption of the substance from the gastro-intestinal-tract is not assumed. In fact, no systemic signs could be observed after oral exposure with 2000 mg/kg bw (BASF SE, 2012).
Despite the log Pow of 5.9 a possible accumulation of HDI oligomerisation product, allophanate-type in adipose tissues is not regarded to be of relevance, since the substance has such a limited systemic availability.
Based on the results of several in vitro genotoxicity tests (OECD TG 471: BASF SE, 2006; OECD TG 476: Harlan, 2012; OECD TG 487: Bayer AG, 2012; all performed with and without metabolic activation) it is concluded that DNA-reactive metabolites of HDI oligomerisation product, allophanate-type will not be generated in mammals in the course of hepatic biotransformation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)